COMMUNIQUÉS West-GlobeNewswire

Mustang Bio to Present at Biotech Innovations Conference
04/04/2018
NEW YORK, April 04, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech (NASDAQ: FBIO ) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]
Tauriga Sciences Inc. Increases its Stake in Crypto Currency Groestlcoin (Code: GRS); Company Now Holds 39,862 GRS Units
04/04/2018
NEW YORK, NY, April 04, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG ) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of [...]
VHA Home HealthCare Honours Outstanding Family Caregivers on National Carers Day
04/04/2018
TORONTO, April 04, 2018 (GLOBE NEWSWIRE) -- VHA Home HealthCare (VHA) honoured three caregiving heroes—Zulfikar Alladina of Toronto, Taylor Allen of Welland, and Madolina Sasa of Scarborough—who won this year’s Heart of [...]
Shire plc : Director Declaration
04/04/2018
Director Declaration April 4, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") announces that Susan Kilsby, Chairman of the Company, was appointed as a Non-Executive Director of Diageo plc on April 4, 2018. [...]
Cannabis Wheaton Announces Definitive Acquisition Agreement With Dosecann
04/04/2018
VANCOUVER, British Columbia, April 04, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX-V: CBW ) (" Cannabis Wheaton " or the " Company ") announces that it has entered into a definitive acquisition agreement [...]
Tonix Pharmaceuticals to Present FDA Breakthrough Therapy-Designated PTSD Program at the MicroCap Conference in New York
04/04/2018
First 50 Percent of Participants Enrolled in Phase 3 HONOR Study of Tonmya® (Cyclobenzaprine HCl Sublingual Tablets) for the Treatment of Military-Related PTSD Interim Results of HONOR Study Expected in Third Quarter [...]
Loxo Oncology Announces Acceptance of LOXO-292 Oral Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting
04/04/2018
STAMFORD, Conn., April 04, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq: LOXO ), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers [...]
Helius Medical Technologies, Inc. Announces Proposed Public Offering of Class A Common Stock and Warrants
04/04/2018
NEWTOWN, Pa., April 04, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX: HSM ) (OTCQB:HSDT) (“ Helius ” or the “ Company ”) announced today that it intends to offer and sell, subject to market conditions [...]
Global Autism Project Partners With Leading Technology and Behavioral Health Experts Rethink
04/04/2018
NEW YORK, April 04, 2018 (GLOBE NEWSWIRE) -- Global Autism Project is excited to announce their new partnership with leading technology and behavioral health experts, Rethink Behavioral Health. In this collaboration, [...]
Curetis' Unyvero BCU Blood Culture Application Receives Approval from Singapore Health Sciences Authority
04/04/2018
Curetis ' Unyvero BCU Blood Culture Application Receives Approval from Singapore Health Sciences Authority Second market authorization for Unyvero Cartridges this year in Singapore Amsterdam, the Netherlands, and [...]
Amarin Updates First Quarter Revenue Guidance, Reiterates Full Year Guidance and Updates on REDUCE-IT Cardiovascular Outcomes Study Progress and Vascepa® Promotion Initiatives
04/04/2018
Over 97% of Final Patient Visits in REDUCE-IT Completed or Scheduled for Near-Term Completion BEDMINSTER, N.J. and DUBLIN, Ireland, April 04, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a [...]
Amarin’s REDUCE-IT Cardiovascular Outcomes Study Reaches 100% Mark for Estimated Onset of Target Primary Major Adverse Cardiovascular Events
04/04/2018
On Track to Report REDUCE-IT Results Before the End of Q3 2018 BEDMINSTER, N.J., and DUBLIN, Ireland, April 04, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the [...]
Helsinn Group and Glenmark Pharmaceuticals enter into an exclusive licensing agreement for launch of AKYNZEO® in India and Nepal
04/04/2018
Helsinn Group and Glenmark Pharmaceuticals enter into an exclusive licensing agreement for launch of AKYNZEO® in India and Nepal AKYNZEO®, containing netupitant 300mg and palonosetron 0.5mg, is used for prevention of [...]
Curetis to Hold Investor Conference Call with Webcast on U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge today
04/04/2018
Curetis to Hold Investor Conference Call with Webcast on U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge today Amsterdam, the Netherlands, San Diego, CA, USA, and [...]
RefleXion Medical Raises $100 Million Series C to Commercialize Revolutionary Cancer Treatment
04/04/2018
World’s Only Biology-Guided Radiation Therapy Could Help Millions More Patients Worldwide HAYWARD, Calif., April 04, 2018 (GLOBE NEWSWIRE) -- RefleXion Medical, a medical technology company developing the first and only [...]
NOTICE OF BIOHIT OYJ’S ANNUAL GENERAL MEETING
04/04/2018
Biohit Oyj Stock Exchange Release April 4, 2018 at 9:30 am local time (EEST) Biohit Oyj shareholders are invited to attend the company’s Annual General Meeting to be held on Wednesday, April 25, 2018 starting at 5:00 pm [...]
CellaVision AB: Notice of 2018 Annual General Meeting of CellaVision (publ)
04/04/2018
The shareholders in CellaVision AB are hereby summoned to the Annual General Meeting, to be held on May 4, 2018 at 15.00 at CellaVision AB, Mobilvägen 12, Ideon in Lund, Sweden. Registration begins at 14:30. The [...]
Shire plc : Rule 2.9 Announcement
04/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 4 April 2018 Shire [...]
ThromboGenics Reports Initial Data from its Clinical Study evaluating THR-317, an anti-PlGF, for the Treatment of Diabetic Macular Edema (DME)
04/04/2018
Press release Study results demonstrate safety and tolerability of THR-317 for intra-ocular use 30% of anti-VEGF treatment naïve patients had a 3 line or more (> or equal to 15 letters) gain in Best Corrected Visual [...]

Pages